myeloproliferative diseases

1

Hematostatic Function in Myeloproliferative Diseases

骨髓增生性疾病止血功能的研究
2

Clinical study of homoharringtonine and low-dose cytarabine in myeloproliferative diseases

高三尖杉酯碱联合小剂量阿糖胞苷治疗骨髓增殖性疾病疗效观察
3

Clinical observation of hemapheresis and chemotherapy for myeloproliferative diseases

血细胞单采去除术联合化疗治疗骨髓增殖性疾病临床疗效观察
4

In BCR-ABL fusion gene negative myeloproliferative diseases , the discovery of JAK2V617F point mutation is an important landmark .

在BCR-ABL阴性的骨髓增殖性疾病的发病机制中，JAK2V617F点突变的发现是一个重大的突破。
5

Methords Hemapheresis was done once or twice weekly , followed by hydroxyurea chemotherapy in 38 patients with of myeloproliferative diseases .

方法38例骨髓增殖性疾病进行血细胞单采去除术每周1~2次，同时给予羟基脲化疗。